+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2017-05-31Number of Pages: 93

Molecular Diagnostics Market (Product - Real-time PCR Systems, Liquid Handling Systems, and DNA Extraction Systems; End User - Hospitals, Diagnostic Laboratories, Academic and Research Institutes, and Pharmaceutical and Biotechnology Companies) - Europe Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2017 - 2025

1. Preface
      1.1. Market Definition and Scope
      1.2. Market Segmentation
      1.3. Key Research Objectives
      1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Europe Molecular Diagnostics Market

4. Market Overview
      4.1. Introduction
      4.2. Key Market Indicators
      4.3. Market Dynamics
            4.3.1. Drivers
            4.3.2. Restraints
            4.3.3. Opportunity
      4.4. Europe Molecular Diagnostics Market Analysis and Forecasts, 2015–2025
            4.4.1. Market Revenue (US$ Mn) and Volume (units) Projections
            4.4.2. Installed Base- Global (units) 
      4.5. Porter’s Five Force Analysis
      4.6. Value Chain Analysis
      4.8. Regulatory approval process
      4.9. Market Outlook

5. Europe Molecular Diagnostics Market Analysis and Forecasts, By Product 
      5.1. Introduction & Definition 
      5.2. Key Findings / Developments 
      5.3. Key Trends 
      5.4. Market Size (US$ Mn) and Volume (Units) Forecast, By Product
            5.4.1. Real Time- PCR Systems 
                     5.4.1.1. LightCycler 480 
                     5.4.1.2. PCRmax Eco 48 
                     5.4.1.3. Applied Biosystems 7900HT 
                     5.4.1.4. QuantStudio Real-Time PCR 
                     5.4.1.5. ViiA 7 Real-Time PCR 
                     5.4.1.6. C1000 Touch 
                     5.4.1.7. ABI StepOnePlus Real-Time PCR 
                     5.4.1.8. ABI 7500 
                     5.4.1.9. AriaMx Real-time PCR System 
                     5.4.1.10. CFX Connect 
                     5.4.1.11. CFX384 Touch 
                     5.4.1.12. MiniOpticon 
                     5.4.1.13. Others 
            5.4.2. Liquid Handling System 
                     5.4.2.1. epMotion 
                     5.4.2.2. Biomek 
                     5.4.2.3. Freedom EVO 
                     5.4.2.4. Tecan D300e Digital Dispenser 
                     5.4.2.5. Precision 
                     5.4.2.6. JANUS 
                     5.4.2.7. Others
            5.4.3. DNA Extraction System 
                     5.4.3.1. AutoMate Express 
                     5.4.3.2. QIAcube 
                     5.4.3.3. InnuPure 
                     5.4.3.4. VERSA 
                     5.4.3.5. chemagic 
                     5.4.3.6. Others
      5.5. Market Attractiveness, By Product

6. Europe Molecular Diagnostics Market Analysis and Forecasts, By End-user 
      6.1. Introduction & Definition 
      6.2. Key Findings / Developments 
      6.3. Key Trends
      6.4. Market Size (US$ Mn) and volume (units) Forecast, By End-user 
            6.4.1. Hospital 
            6.4.2. Diagnostics Laboratories 
            6.4.3. Academics & Research Institutes 
            6.4.4. Pharmaceutical & Biotechnology Companies 
      6.5. Market Attractiveness By End-user

7. Molecular Diagnostics Market Analysis and Forecasts, By Country 
      7.1. Introduction & Definition 
      7.2. Key Findings / Developments 
      7.3. Market Size (US$ Mn) Forecast, By Country 
            7.3.1. U.K. 
            7.3.2. France 
            7.3.3. Germany 
            7.3.4. Italy 
            7.3.5. Spain 
            7.3.6. Rest of Europe 
      7.4. Market Attractiveness By Country

8. Competition Landscape
      8.1. Market Player – Competition Matrix (By Tier and Size of companies)
      8.2. Market Share Analysis By Company (2016)
      8.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
            8.3.1. Agilent Technologies, Inc.
                     8.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                     8.3.1.2. Business Overview
                     8.3.1.3. Product Portfolio 
                     8.3.1.4. Financial Overview 
                     8.3.1.5. SWOT Analysis 
                     8.3.1.6. Strategic overview
            8.3.2. Becton, Dickinson and Company
                     8.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                     8.3.2.2. Business Overview
                     8.3.2.3. Product Portfolio 
                     8.3.2.4. Financial Overview 
                     8.3.2.5. SWOT Analysis 
                     8.3.2.6. Strategic overview
            8.3.3. Bio-Rad Laboratories, Inc.
                     8.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                     8.3.3.2. Business Overview
                     8.3.3.3. Product Portfolio 
                     8.3.3.4. Financial Overview 
                     8.3.3.5. SWOT Analysis 
                     8.3.3.6. Strategic overview
            8.3.4. Danaher Corporation
                     8.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                     8.3.4.2. Business Overview
                     8.3.4.3. Product Portfolio 
                     8.3.4.4. Financial Overview 
                     8.3.4.5. SWOT Analysis 
                     8.3.4.6. Strategic overview
            8.3.5. Eppendorf AG
                     8.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                     8.3.5.2. Business Overview
                     8.3.5.3. Product Portfolio 
                     8.3.5.4. Financial Overview 
                     8.3.5.5. SWOT Analysis 
                     8.3.5.6. Strategic overview
            8.3.6. F. Hoffmann-La Roche Ltd.
                     8.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                     8.3.6.2. Business Overview
                     8.3.6.3. Product Portfolio 
                     8.3.6.4. Financial Overview 
                     8.3.6.5. SWOT Analysis 
                     8.3.6.6. Strategic overview
            8.3.7. PerkinElmer, Inc.
                     8.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                     8.3.7.2. Business Overview
                     8.3.7.3. Product Portfolio 
                     8.3.7.4. Financial Overview 
                     8.3.7.5. SWOT Analysis 
                     8.3.7.6. Strategic overview
            8.3.8. QIAGEN N.V.
                     8.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                     8.3.8.2. Business Overview
                     8.3.8.3. Product Portfolio 
                     8.3.8.4. Financial Overview 
                     8.3.8.5. SWOT Analysis 
                     8.3.8.6. Strategic overview
            8.3.9. Tecan Group Ltd.
                     8.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
                     8.3.9.2. Business Overview
                     8.3.9.3. Product Portfolio 
                     8.3.9.4. Financial Overview 
                     8.3.9.5. SWOT Analysis 
                     8.3.9.6. Strategic overview
            8.3.10. Thermo Fisher Scientific, Inc.
                     8.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
                     8.3.10.2. Business Overview
                     8.3.10.3. Product Portfolio 
                     8.3.10.4. Financial Overview 
                     8.3.10.5. SWOT Analysis 
                     8.3.10.6. Strategic overview

List of Figures

Figure 01: Europe Molecular Diagnostics Market Size (US$ Mn) and Volume (units), and Forecast, 2017–2025
Figure 02: Market Value Share By Product (2017)
Figure 03: Market Value Share By End-user (2017)
Figure 04: Market Value Share By Country (2017)
Figure 05: Europe Molecular Diagnostics Market Value Share Analysis, by Product, 2016 and 2025
Figure 06: Europe Real-time PCR Systems Market Revenue (US$ Mn) and Volume (Units), 2015–2025
Figure 07: Europe Liquid Handling Systems Market Revenue (US$ Mn) and Volume (Units), 2015–2025
Figure 08: Europe DNA Extraction Systems Market Revenue (US$ Mn) and Volume (Units), 2015–2025
Figure 09: Europe Molecular Diagnostics Market Attractiveness Analysis, by Product
Figure 10: Europe Molecular Diagnostics Market Value Share Analysis, by End-user, 2016 and 2025
Figure 11: Europe Hospitals Market Revenue (US$ Mn) and Volume (Units) 2015–2025
Figure 12: Europe Diagnostic Laboratories Market Revenue (US$ Mn) and Volume (Units), 2015–2025
Figure 13: Europe Academic and Research Institutes Market Revenue (US$ Mn) and Volume (Units), 2015–2025
Figure 14: Europe Pharmaceutical and Biotechnology Companies Market Revenue (US$ Mn) and Volume (Units), 2015–2025
Figure 15: Molecular Diagnostics Market Attractiveness Analysis, by End-user
Figure 16: Europe Molecular Diagnostics Market Value Share Analysis, by Country, 2016 and 2025
Figure 17: Europe Molecular Diagnostics Market Attractiveness Analysis, by Country
Figure 18: Europe Molecular Diagnostics Market Share Analysis, by Company (2016)

List of Tables

Table 01: Europe Molecular Diagnostics Market Size (US$ Mn) and Volume (Units) Forecast, by Product, 2017–2025
Table 02: Europe Molecular Diagnostics Market Size (US$ Mn) and Volume (Units) Forecast, by Product – Real-time PCR Systems, 2017–2025
Table 03: Europe Molecular Diagnostics Market Size (US$ Mn) and Volume (Units) Forecast, by Product – Liquid Handling Systems, 2017–2025
Table 04: Europe Molecular Diagnostics Market Size (US$ Mn) and Volume (Units) Forecast, by Product – DNA Extraction Systems, 2017–2025
Table 05: Europe Molecular Diagnostics Market Size (US$ Mn) and Volume (Units) Forecast, by End-user, 2015–2025
Table 06: Europe Molecular Diagnostics Market Size (US$ Mn) Forecast, by Country, 2017–2025    


 
 
Back To Top